The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
HER2 amplification in EGFR mutant NSCLC after acquired resistance (AR) to EGFR-directed therapies.
 
Bing Xia
No Relationships to Disclose
 
Anna Wurtz
No Relationships to Disclose
 
Scott N. Gettinger
Consulting or Advisory Role - ARIAD; Bristol-Myers Squibb; Janssen
Research Funding - ARIAD (Inst); AstraZeneca/MedImmune (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Incyte (Inst); Pfizer (Inst)
 
Roy S. Herbst
Honoraria - AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech/Roche; Lilly; Merck; NovaRX; pfizer
Consulting or Advisory Role - Biothera; DiaTech Oncology; Endocyte; Kolltan Pharmaceuticals; N-of-One
Research Funding - Genentech/Roche
 
Anne C. Chiang
Consulting or Advisory Role - Genentech; Genentech/Roche
Research Funding - Boehringer Ingelheim; Millennium; OncoMed; Onyx
 
Mimi Wan
Employment - Ambry Genetics
 
Jeffrey Sklar
No Relationships to Disclose
 
Veronique Neumeister
Consulting or Advisory Role - Mitsubishi Tanabe Pharma (I)
 
Katerina A Politi
Research Funding - AstraZeneca; Gilead Sciences; Kolltan Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Memorial Sloan-Kettering Cancer Center; MolecularMD
 
Sarah B. Goldberg
Consulting or Advisory Role - Clovis Oncology
Research Funding - AstraZeneca; Genentech (Inst); Immunogen (Inst); Kadmon (Inst); Merck (Inst)